NDC 60977-145

DAPZURA RT

Daptomycin

DAPZURA RT is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Daptomycin.

• Product ID: 60977-145_9e787d97-fb85-4d5f-8543-22a671d32006
• NDC: 60977-145
• Product Type: Human Prescription Drug
• Proprietary Name: DAPZURA RT
• Generic Name: Daptomycin
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-01-25
• Marketing Category: NDA /
• Application Number: NDA213645
• Labeler Name: Baxter Healthcare Corporation
• Substance Name: DAPTOMYCIN
• Active Ingredient Strength: 500 mg/10mL
• Pharm Classes: Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 60977-145-01

1 VIAL in 1 CARTON (60977-145-01) > 10 mL in 1 VIAL

• Marketing Start Date: 2022-01-25
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "DAPZURA RT" or generic name "Daptomycin"

NDC	Brand Name	Generic Name
0143-9378	Daptomycin	Daptomycin
0409-0106	Daptomycin	DAPTOMYCIN
0409-0120	Daptomycin	DAPTOMYCIN
0409-0122	Daptomycin	DAPTOMYCIN
0409-2757	Daptomycin	DAPTOMYCIN
0409-5933	Daptomycin	Daptomycin
0703-0125	Daptomycin	Daptomycin
0781-3295	daptomycin	daptomycin
16714-892	Daptomycin	Daptomycin
16729-434	Daptomycin	Daptomycin
16729-435	DAPTOMYCIN	Daptomycin
25021-174	daptomycin	daptomycin
25021-179	Daptomycin	Daptomycin